Becton, Dickinson and Company vs Merck & Company, Inc. — Stock Comparison

BDX
Becton, Dickinson and Company
$149.31
▲ 0.18%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Becton, Dickinson and Company
BDX6.7/10vs 6.7/10

Q·Score Breakdown

6.7
Neutral
Overall
6.7
Neutral
6
Quality
6.2
7
Health
7
7.4
Growth
6.2
7.7
Valuation
7.2
5.2
Sentiment
7.1
BDX

Consensus analyst target of $191.46 is 28% above current price.

analyst sentiment is cautious.

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $191.46 (+28.2%)
13 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

BDX
MRK
24.4×
Trailing P/E
31.5×
11.1×
Forward P/E
11.5×
8.0%
Profit Margin
13.6%
46.8%
Gross Margin
76.6%
7.0%
ROE
1.6%
Revenue Growth
4.9%
28.6%
Earnings Growth
0.35
Beta
0.28
Price / Book
$42.5B
Market Cap
$277.0B
$128 – $187
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →